ATE252089T1 - Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln - Google Patents

Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln

Info

Publication number
ATE252089T1
ATE252089T1 AT98939674T AT98939674T ATE252089T1 AT E252089 T1 ATE252089 T1 AT E252089T1 AT 98939674 T AT98939674 T AT 98939674T AT 98939674 T AT98939674 T AT 98939674T AT E252089 T1 ATE252089 T1 AT E252089T1
Authority
AT
Austria
Prior art keywords
choh
chain
ch2oh
production
products containing
Prior art date
Application number
AT98939674T
Other languages
English (en)
Inventor
Georges Bashiardes
Jean-Christophe Carry
Michel Evers
Bruno Filoche
Serge Mignani
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9709056A external-priority patent/FR2766181B1/fr
Priority claimed from FR9709206A external-priority patent/FR2766186B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE252089T1 publication Critical patent/ATE252089T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT98939674T 1997-07-17 1998-07-15 Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln ATE252089T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9709056A FR2766181B1 (fr) 1997-07-17 1997-07-17 Derives de polyhydroxybutylpyrazines, leur preparation et les medicaments les contenant
FR9709206A FR2766186B1 (fr) 1997-07-21 1997-07-21 Medicaments contenant des derives de polyhydroxyalkylpyrazine, les nouveaux derives de polyhydroxyalkylpyrazine et leur preparation
PCT/FR1998/001540 WO1999003839A1 (fr) 1997-07-17 1998-07-15 Derives de polyhydroxyalkylpyrazines, leur preparation et les medicaments les contenant

Publications (1)

Publication Number Publication Date
ATE252089T1 true ATE252089T1 (de) 2003-11-15

Family

ID=26233681

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98939674T ATE252089T1 (de) 1997-07-17 1998-07-15 Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln

Country Status (21)

Country Link
US (1) US6362185B1 (de)
EP (1) EP0998464B1 (de)
JP (1) JP4443032B2 (de)
KR (1) KR20010021815A (de)
CN (1) CN1264369A (de)
AT (1) ATE252089T1 (de)
AU (1) AU751588B2 (de)
BR (1) BR9810893A (de)
CA (1) CA2296732C (de)
DE (1) DE69819002T2 (de)
DK (1) DK0998464T3 (de)
ES (1) ES2205535T3 (de)
HU (1) HUP0002403A3 (de)
IL (1) IL134036A0 (de)
MX (1) MXPA00000443A (de)
NO (1) NO20000054D0 (de)
NZ (1) NZ502055A (de)
PL (1) PL338132A1 (de)
RU (1) RU2193032C2 (de)
SK (1) SK452000A3 (de)
WO (1) WO1999003839A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114401992A (zh) 2019-07-05 2022-04-26 艾欧麦克斯治疗股份公司 结合igsf11（vsig3）的igc2的抗体及其用途
CN111266090B (zh) * 2020-02-19 2022-11-15 渤海大学 一种快速吸附和选择性分离阳离子染料污染物的吸附分离材料及其应用
US20240010720A1 (en) 2020-07-06 2024-01-11 Iomx Therapeutics Ag Antibodies binding igv of igsf11 (vsig3) and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0729990A (ja) * 1993-07-14 1995-01-31 Fujitsu Ltd 半導体装置
FR2744365B1 (fr) * 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments

Also Published As

Publication number Publication date
EP0998464A1 (de) 2000-05-10
IL134036A0 (en) 2001-04-30
HUP0002403A3 (en) 2001-07-30
AU751588B2 (en) 2002-08-22
JP2001510184A (ja) 2001-07-31
AU8810098A (en) 1999-02-10
NZ502055A (en) 2001-09-28
DE69819002T2 (de) 2004-07-29
KR20010021815A (ko) 2001-03-15
PL338132A1 (en) 2000-09-25
DK0998464T3 (da) 2004-02-16
CN1264369A (zh) 2000-08-23
HUP0002403A2 (en) 2001-05-28
BR9810893A (pt) 2000-09-26
DE69819002D1 (de) 2003-11-20
CA2296732C (fr) 2008-10-21
NO20000054L (no) 2000-01-06
ES2205535T3 (es) 2004-05-01
WO1999003839A1 (fr) 1999-01-28
RU2193032C2 (ru) 2002-11-20
US6362185B1 (en) 2002-03-26
CA2296732A1 (fr) 1999-01-28
EP0998464B1 (de) 2003-10-15
NO20000054D0 (no) 2000-01-06
SK452000A3 (en) 2000-06-12
JP4443032B2 (ja) 2010-03-31
MXPA00000443A (es) 2002-04-17

Similar Documents

Publication Publication Date Title
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
EE200100558A (et) Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
DE69817802D1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
ATE161836T1 (de) 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate
TR200200648T2 (tr) Farmasötik özelliklere sahip yeni dikarboksilik asit türevleri.
DE69738245D1 (de) 1,2-Diphenylpyrrol-Derivate, ihre Herstellung und therapeutische Verwendung
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
MY128659A (en) Novel aminodicarboxylic acid derivatives having pharmaceutical properties
ATE288443T1 (de) Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediate zu beider herstellung
DE3777544D1 (de) Glutaminsaeure-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische formulierungen.
PT992509E (pt) Novos derivados macrolidos
DK132188A (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
ATE260252T1 (de) Thiocolchicin-derivate mit entzündungshemmender und muskelrelaxierender wirkung
ATE252089T1 (de) Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln
ATE115558T1 (de) Harnstoffderivate, deren herstellung sowie diese enthaltende pharmazeutische zusammensetzungen.
HUP9601526A2 (hu) Véralvadásgátló hatású peptidil-arginin-aldehid-származékok és a vegyületeket tartalmazó gyógyszerkészítmények
DE69030502D1 (de) Cephalosporinverbindungen und deren herstellung
DE69917668D1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
ATE140922T1 (de) 3- oder 4-glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches mittel
DE3872425D1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
DE3880304D1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
DE69511449D1 (de) Octahydro-2-Naphthalincarbonsäure-Derivate, ihre Herstellung und Verwendung
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
ATE241604T1 (de) Polyhydroxyalkylpyrazine derivate und deren herstellung und diese enthaltende arzneimittel
ATE167869T1 (de) Thiolderivate von gallensäure

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties